.png){kind=icon}
返回
Uncommon Blepharitis
.png){kind=icon}
OA
AI
DOI：10.3390/jcm13030710.png)
.png){kind=icon}
.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
Blepharitis is a common chronic inflammatory condition affecting the eyelid margins; the pathophysiology of blepharitis is complex and not fully understood. The disease is anatomically divided into anterior (inflammation of eyelashes) and posterior (meibomian gland dysfunction) types. Diagnosis relies on clinical examination, revealing characteristic features like scurf, vascular changes, and meibomian gland dysfunction. The main goals of blepharitis treatment are symptom relief, recurrence prevention, and complication risk minimization. Treatment options include lid hygiene, topical and systemic antibiotics, topical corticosteroids, and omega-3 supplements. However, it is important to highlight reported cases of blepharitis as side effects of systemic therapies, particularly in the context of chemotherapy, bortezomib, cetuximab, TNF alpha inhibitors, and dupilumab. It is crucial to monitor patients undergoing such treatments regularly and attentively in order to promptly set up adequate supportive therapy. Of even more importance is future research on the pathophysiological mechanisms responsible for the occurrence of these ocular side effects in order to find a nosological cure for the issue.
Keyword:
blepharitis
anterior blepharitis
posterior blepharitis
meibomian gland dysfunction
blepharitis treatment
bortezomib
cetuximab
TNF-alpha inhibitors
dupilumab
AI总结
对已上传原文的论文进行重点信息的提取，主要内容包括：简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
2.9
论文数:
5.1W
被引数:
9.8W
机构
引用论文
分享收藏The ophthalmological complications of targeted agents in cancer therapy: what do we need to know as ophthalmologists?.png)
ACTA OPHTHALMOLOGICA
OAAI
ACTA OPHTHALMOLOGICAIF2.8
OAAI分享收藏Neuropsychological correlates of schizotypy: a systematic review and meta-analysis of cross-sectional studies精神分裂症的神经心理学相关性: 横断面研究的系统评价和荟萃分析
PREAI
分享收藏
查看更多内容